Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lysosome-associated membrane proteins (LAMPs) are a family of highly glycosylated, integral membrane proteins that constitute about 50% of the protein content in the lysosomal membrane. The most prominent members in mammals are LAMP1 and LAMP2, which play crucial roles in maintaining lysosomal integrity, regulating pH, and facilitating catabolic processes within the lysosome. LAMPs are involved in autophagy regulation and serve as carbohydrate ligands for selectins, mediating cell-cell adhesion. LAMP2 has three isoforms: LAMP2A, LAMP2B, and LAMP2C, each with specific functions. Deficiency or mutation in LAMP2 causes Danon disease. Overexpression/surface localization correlates with increased metastatic potential in several cancers.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lysosome-associated Membrane Protein (LAMP).